MetaADEDB 2.0 @ LMMD
Namzaric
(HDXRNOHHJUFFNT-UHFFFAOYSA-N)
Structure
SMILES
CC12CC3CC(C1)(C)CC(C2)(C3)N.COc1cc2c(cc1OC)CC(C2=O)CC1CCN(CC1)Cc1ccccc1.Cl.Cl
Molecular Formula:
C36H52Cl2N2O3
Molecular Weight:
631.716
Log P:
9.2974
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
64.79
CAS Number(s):
914296-81-4
Synonym(s)
1.
Namzaric
External Link(s)
MeSHC000610194
PubChem Compound76037163
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 19US FAERS
2NauseaFAERS: 12US FAERS
3VomitingFAERS: 12US FAERS
4FatigueFAERS: 9US FAERS
5Drug ineffectiveFAERS: 5US FAERS
6Expired product administeredFAERS: 4US FAERS
7HeadacheFAERS: 4US FAERS
8MalaiseFAERS: 4US FAERS
9AgitationFAERS: 3US FAERS
10AtaxiaFAERS: 3US FAERS
11Feeling abnormalFAERS: 3US FAERS
12Intentional product misuseFAERS: 3US FAERS
13Product dose omissionFAERS: 3US FAERS
14Abdominal discomfortFAERS: 2US FAERS
15BradycardiaFAERS: 2US FAERS
16Chest PainFAERS: 2US FAERS
17DehydrationFAERS: 2US FAERS
18DementiaFAERS: 2US FAERS
19DiplopiaFAERS: 2US FAERS
20DisorientationFAERS: 2US FAERS
21Drug dose omissionFAERS: 2US FAERS
22Flat affectFAERS: 2US FAERS
23Inappropriate schedule of product administrationFAERS: 2US FAERS
24Incorrect dose administeredFAERS: 2US FAERS
25Mental status changesFAERS: 2US FAERS
26Product prescribing errorFAERS: 2US FAERS
27SyncopeFAERS: 2US FAERS
28Unresponsive to stimuliFAERS: 2US FAERS
29AlopeciaFAERS: 1US FAERS
30AngerFAERS: 1US FAERS
31AnxietyFAERS: 1US FAERS
32AphasiaFAERS: 1US FAERS
33Back PainFAERS: 1US FAERS
34BlindnessFAERS: 1US FAERS
35Blood glucose increasedFAERS: 1US FAERS
36Blood sodium decreasedFAERS: 1US FAERS
37ChillsFAERS: 1US FAERS
38CryingFAERS: 1US FAERS
39Drug ineffective for unapproved indicationFAERS: 1US FAERS
40Drug prescribing errorFAERS: 1US FAERS
41Drug titration errorFAERS: 1US FAERS
42Drug withdrawal syndromeFAERS: 1US FAERS
43DysarthriaFAERS: 1US FAERS
44EructationFAERS: 1US FAERS
45General physical health deteriorationFAERS: 1US FAERS
46Head discomfortFAERS: 1US FAERS
47HemiparesisFAERS: 1US FAERS
48HypotensionFAERS: 1US FAERS
49Inappropriate schedule of drug administrationFAERS: 1US FAERS
50LethargyFAERS: 1US FAERS
51Loss of personal independence in daily activitiesFAERS: 1US FAERS
52Medication ErrorFAERS: 1US FAERS
53Myocardial InfarctionFAERS: 1US FAERS
54Neck PainFAERS: 1US FAERS
55NervousnessFAERS: 1US FAERS
56ParanoiaFAERS: 1US FAERS
57Peripheral swellingFAERS: 1US FAERS
58Phobia of drivingFAERS: 1US FAERS
59PneumoniaFAERS: 1US FAERS
60PolyuriaFAERS: 1US FAERS
61Product availability issueFAERS: 1US FAERS
62RetchingFAERS: 1US FAERS
63Sexual DysfunctionFAERS: 1US FAERS
64Sudden deathFAERS: 1US FAERS
65Tongue movement disturbanceFAERS: 1US FAERS
66UrticariaFAERS: 1US FAERS
67Weight decreasedFAERS: 1US FAERS
68White blood cell count decreasedFAERS: 1US FAERS
69Wrong drug administeredFAERS: 1US FAERS
70Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.